ATE556728T1 - Gewebeaufbaugerüste mit homingfaktoren - Google Patents

Gewebeaufbaugerüste mit homingfaktoren

Info

Publication number
ATE556728T1
ATE556728T1 AT10165816T AT10165816T ATE556728T1 AT E556728 T1 ATE556728 T1 AT E556728T1 AT 10165816 T AT10165816 T AT 10165816T AT 10165816 T AT10165816 T AT 10165816T AT E556728 T1 ATE556728 T1 AT E556728T1
Authority
AT
Austria
Prior art keywords
factors
homining
tissue structures
receptor
scaffold
Prior art date
Application number
AT10165816T
Other languages
English (en)
Inventor
Willem Flameng
Visscher Geofrey De
Original Assignee
Leuven K U Res & Dev
Alphagen N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leuven K U Res & Dev, Alphagen N V filed Critical Leuven K U Res & Dev
Application granted granted Critical
Publication of ATE556728T1 publication Critical patent/ATE556728T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625—Vascular tissue, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645—Connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Filters For Electric Vacuum Cleaners (AREA)
  • Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
  • Emergency Lowering Means (AREA)
  • Helmets And Other Head Coverings (AREA)
  • Ladders (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT10165816T 2004-11-08 2005-11-08 Gewebeaufbaugerüste mit homingfaktoren ATE556728T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0424560A GB0424560D0 (en) 2004-11-08 2004-11-08 Heart valve tissue engineering
US66076605P 2005-03-11 2005-03-11

Publications (1)

Publication Number Publication Date
ATE556728T1 true ATE556728T1 (de) 2012-05-15

Family

ID=33523291

Family Applications (2)

Application Number Title Priority Date Filing Date
AT10165816T ATE556728T1 (de) 2004-11-08 2005-11-08 Gewebeaufbaugerüste mit homingfaktoren
AT05808071T ATE471169T1 (de) 2004-11-08 2005-11-08 Engineering mit homing-faktoren

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT05808071T ATE471169T1 (de) 2004-11-08 2005-11-08 Engineering mit homing-faktoren

Country Status (12)

Country Link
US (1) US20070264306A1 (de)
EP (2) EP1812088B1 (de)
JP (1) JP4854670B2 (de)
CN (1) CN101094697B (de)
AT (2) ATE556728T1 (de)
AU (1) AU2005301111B2 (de)
CA (1) CA2582155A1 (de)
DK (2) DK2255834T3 (de)
ES (2) ES2347339T3 (de)
GB (1) GB0424560D0 (de)
PL (1) PL2255834T3 (de)
WO (1) WO2006047841A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1797909A3 (de) * 2005-11-28 2007-09-05 Lifescan, Inc. Zusammensetzungen und Verfahren zur Herstellung einer vaskularisierten Umgebung für Zelltransplantationen
US11051733B2 (en) * 2008-01-18 2021-07-06 Wake Forest University Health Sciences Isolating and purifying cells for therapy
US20130245757A1 (en) * 2011-11-04 2013-09-19 Allergan, Inc. Method and device for improved soft tissue surgery
CA2767164C (en) * 2009-06-11 2019-10-15 Cynthia Bamdad Culturing embryonic stem cells, embryonic stem-like cells or induced pluripotent stem cells with a muc1 or muc1* ligand
WO2011022070A2 (en) * 2009-08-20 2011-02-24 The Regents Of The University Of California Perivascular stem cell composition for bone
WO2011085301A1 (en) * 2010-01-08 2011-07-14 Baxter International Inc. Biomatrices to attract and retain regenerative and reparative cells
CA2830503A1 (en) 2011-03-17 2012-09-20 Minerva Biotechnologies Corporation Method for making pluripotent stem cells
AU2012282660B2 (en) * 2011-07-11 2017-07-27 The Children's Hospital Of Philadelphia Oxidation resistant bioprosthetic tissues and preparation thereof
WO2013101720A1 (en) * 2011-12-28 2013-07-04 The Regents Of The University Of California Implantable vascular devices and methods of use thereof
US11028502B2 (en) * 2017-11-02 2021-06-08 Wake Forest University Health Sciences Vascular constructs
CN108187141A (zh) * 2018-01-31 2018-06-22 广州沙艾生物科技有限公司 一种心脏肌球衍生细胞在生物材料中的应用
CN110898254B (zh) * 2019-12-17 2021-11-30 浙江大学 一种用于修复子宫内膜并提高生育力的生物活性支架
EP4314244B1 (de) * 2021-03-23 2025-07-23 Terumo BCT, Inc. Zellerfassung und -erweiterung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6033784A (en) 1995-04-07 2000-03-07 Jacobsen; Mogens Havsteen Method of photochemical immobilization of ligands using quinones
WO1999000670A1 (en) 1997-06-25 1999-01-07 Innogenetics N.V. Methods for covalent immobilisation of biomolecules to a carrier by means of a his-tag
WO1999026674A2 (de) 1997-11-24 1999-06-03 Jennissen Herbert P Verfahren zur immobilisierung von mediatormolekülen auf anorganischen und metallischen implantatmaterialien
US6082364A (en) * 1997-12-15 2000-07-04 Musculoskeletal Development Enterprises, Llc Pluripotential bone marrow cell line and methods of using the same
US6573101B1 (en) * 1998-02-12 2003-06-03 The Regents Of The University Of California Compositions for receptor/liposome mediated transfection and methods of using same
EP1123067A2 (de) * 1998-10-20 2001-08-16 TEI Biosciences, Inc. Kardiovaskuläre komponenten zur transplantation und herstellungsverfahren dafür
DE19904975A1 (de) 1999-02-06 2000-09-14 Impella Cardiotech Ag Vorrichtung zur intravasalen Herzklappenoperation
AU2001237805A1 (en) 2000-02-08 2001-08-20 Acspurt B.V. Material and method for immobilization of bioactive species
US6652583B2 (en) * 2000-04-07 2003-11-25 Rhode Island Hospital Cardiac valve replacement
WO2002102432A1 (en) * 2001-06-15 2002-12-27 Johns Hopkins Singapore Pte Ltd Biofunctional fibers
AU2003263212A1 (en) * 2002-08-14 2004-03-03 Avidis Sa Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use
AU2003286425A1 (en) * 2002-12-05 2004-06-23 Cardio Incorporated Layered bioresorbable implant
US20040126405A1 (en) * 2002-12-30 2004-07-01 Scimed Life Systems, Inc. Engineered scaffolds for promoting growth of cells
EP1611233B1 (de) * 2003-04-08 2016-01-06 Yeda Research And Development Co., Ltd. Stammzellen mit erhöhter empfindlichkeit für sdf-1 sowie methoden zu deren herstellung und verwendung
US20050148512A1 (en) * 2003-11-10 2005-07-07 Angiotech International Ag Medical implants and fibrosis-inducing agents

Also Published As

Publication number Publication date
JP4854670B2 (ja) 2012-01-18
CN101094697B (zh) 2011-08-10
WO2006047841A3 (en) 2006-08-24
EP2255834A1 (de) 2010-12-01
CN101094697A (zh) 2007-12-26
AU2005301111A1 (en) 2006-05-11
DK2255834T3 (da) 2012-06-18
CA2582155A1 (en) 2006-05-11
US20070264306A1 (en) 2007-11-15
DK1812088T3 (da) 2010-09-20
GB0424560D0 (en) 2004-12-08
WO2006047841A2 (en) 2006-05-11
EP2255834B1 (de) 2012-05-09
ATE471169T1 (de) 2010-07-15
ES2385785T3 (es) 2012-07-31
ES2347339T3 (es) 2010-10-28
PL2255834T3 (pl) 2012-09-28
EP1812088B1 (de) 2010-06-16
AU2005301111B2 (en) 2011-11-17
EP1812088A2 (de) 2007-08-01
JP2008518606A (ja) 2008-06-05

Similar Documents

Publication Publication Date Title
ATE556728T1 (de) Gewebeaufbaugerüste mit homingfaktoren
NZ592973A (en) Compositions and methods of using angiopoietin-like 4 protein
CR20110470A (es) Proteínas de union a il-17
AR060862A1 (es) Proteinas de fusion rage, formulaciones y metodos de uso de estas
CR10147A (es) "ligandos que tienen especificidad de enlace para vegf y/o egfr y métodos de uso de los mismos"
EA200801172A1 (ru) Лиганды, имеющие специфичность связывания в отношении рецептора эпидермального фактора роста (egfr) и/или сосудистого эндотелиального фактора роста (vegf), и способы их применения
EP1991560A4 (de) Peptid mit zellmembranpenetrierender wirkung
MX2010002716A (es) Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
PE20140232A1 (es) Proteinas de enlace antigeno capaz de enlazar linfopoyetina estromal timica
WO2011005540A8 (en) Methods and compositions using peptides and proteins with c-terminal elements
BRPI0721137B8 (pt) compostos para modulação de atividade de c-fms e/ou kit, composição, kit e uso dos referidos compostos.
BRPI0921999B8 (pt) uso de uma quantidade terapeuticamente eficaz de células tronco placentárias
WO2008079973A9 (en) Egfr binding peptides and uses thereof
GT201200236A (es) Polipéptidos agonistas que se enlazan a dr5
ECSP077416A (es) Mimeticuerpos que se unen al receptor de melanocortina, composiciones, metodos y usos
WO2008063424A3 (en) Methods of promoting cardiac repair using growth factors fused to heparin binding sequences
EA200900537A1 (ru) Высокоаффинный сайт связывания hgfr и способы идентификации его антагонистов
WO2004094476A3 (en) Compositions and methods relating to stop-1
CL2008001719A1 (es) Compuestos derivados de [1,10]-fenantrolina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades neurodegenerativas o hematologicas.
WO2008142664A3 (en) Exposed thymidine kinase 1 peptides, ligands and methods employing the same
DE602006013109D1 (de) Markerprotein zur verwendung bei der diagnose von bauchspeicheldrüsenkrebs
WO2007047969A3 (en) Methods of decreasing vascular calcification using il-1 inhibitors
DE602005022686D1 (de) Einpressmörtelmischung zur verwendung bei einer spannbetonkonstruktion
WO2006036871A3 (en) Plant pr-5 proteins as mammalian therapeutic agents
GB0500226D0 (en) Compounds which bind to the active site of protein kinase enzymes